- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about OTIC
Recent news which mentions OTIC
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
From Benzinga
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
From Benzinga
U.S. Stocks Turn Negative; Dow Drops Over 100 Points
August 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 01, 2022
From Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
From Benzinga
U.S. Stocks Turn Higher; Crude Oil Tumbles
August 01, 2022
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 01, 2022
From Benzinga
Otonomy Shares Sink After Stopping Mid-Stage Tinnitus Study
August 01, 2022
Tickers
OTIC
From Benzinga
Earnings Scheduled For July 25, 2022
July 25, 2022
From Benzinga
From Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 23, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 23, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.